A new Alzheimer’s therapy is approved in China, delivering a surprise for the field but also questions
CHINA PHOTOS/GETTY IMAGES
Chinese regulators have granted conditional approval to an Alzheimer’s drug that is derived from seaweed, raising some hopes but also many questions.
No hay comentarios:
Publicar un comentario